克洛皮多格雷尔在多微生物败血症中的肺部保护作用
Ruaa Murtada Mueen1, Najah R Hadi1
1DEPARTMENT OF PHARMACOLOGY & THERAPEUTICS, FACULTY OF MEDICINE, UNIVERSITY OF KUFA, KUFA, IRAQ.
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
|September 27, 2023
概括
克洛皮多格雷尔通过减少炎症和氧化应激标志物,证明了在败血症期间的肺部保护. 这项研究强调了其在败血症引起的肺损伤中的潜在治疗作用.
科学领域:
- 败血症的研究研究.
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 败血症可能导致严重的肺损伤.
- 炎症和氧化应激途径是导致败血症引起的器官损伤的关键因素.
研究的目的:
- 调查克洛皮多格雷尔在败血症期间对肺组织的潜在保护作用.
- 为了确定克洛皮多格雷尔是否能调节败血症中的炎症和氧化应激标志物.
主要方法:
- 成年雄性瑞士白色老鼠接受了结和穿孔 (CLP) 诱导多微生物败血症.
- 在CLP之前,小鼠被用克洛皮多格雷尔或载体治疗.
- 酶相关免疫吸收试验 (ELISA) 用于测量肺组织标记物.
主要成果:
- 败血症显著增加了F2异质水平和肺组织损伤.
- 与败血症组相比,克洛皮多格雷尔治疗显著降低了炎症标志物 (IL-1,TNF-α,IL-6),氧化应激 (F2异) 和肺损伤.
- 组织学分析证实,克洛皮多格雷尔治疗小鼠的肺组织损伤减少.
结论:
- 克洛皮多格雷尔有效地降低了小鼠在CLP诱导的败血症期间的肺组织细胞因子度和氧化应激.
- 该药物调节促炎和氧化应激信号通路,提供肺部保护.
- 这项研究是第一个在这种情况下检查克洛皮多格雷尔对巨细胞迁移抑制因子 (MIF) 水平的影响.
相关概念视频
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
552
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
552
Pulmonary Embolism III: Nursing Management
15
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
15
Pulmonary Embolism I: Introduction
7
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
7
Pneumonia II: Pathophysiology
314
The pathophysiology of pneumonia involves the following steps:
314
Pneumonia I: Introduction
262
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
262


